Prothena Corp. Plc(NASDAQ : PRTA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.70%||89.29||1.0%||$695.99m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.59%||768.81||2.6%||$502.61m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.26%||321.59||1.9%||$479.07m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.73%||104.45||4.2%||$163.38m|
|AXSM||Axsome Therapeutics, Inc.||1.09%||79.01||1.6%||$148.54m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.15%||1.85||0.7%||$129.32m|
|RXDX||Prometheus Biosciences, Inc||18.72%||113.74||1.4%||$123.29m|
|MRTX||Mirati Therapeutics, Inc.||-10.73%||44.27||1.6%||$91.13m|
|HALO||Halozyme Therapeutics, Inc.||-0.30%||57.57||18.4%||$81.79m|
Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firmâ€™s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimerâ€™s disease, Parkinsonâ€™s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.